Male hypogonadism.
The hypothalamic-pituitary-gonadal (HPG) axis regulates the development, endocrine and reproductive function of the gonads throughout all phases of life. Male hypogonadism is defined an inadequate gonadal function, as manifested by deficiency in gametogenesis and/or secretion of gonadal hormones. In most cases, male hypogonadism is diagnosed through detailed history, physical examination and a few basic hormonal evaluations. In selected cases, however, additional tests are needed to define the aetiology and the extent of HPG axis dysfunction. These include semen analysis, pituitary imaging studies, genetic studies, bone densitometry, testicular ultrasonography, testicular biopsy and hormonal dynamic testing. The stimulation tests of the HPG are of particular importance in the differential diagnosis of congenital delayed puberty versus pre-pubertal hypogonadism in children. This review will focus on the methods, indications and limitations of endocrine testing in the characterisation and differential diagnosis of male hypogonadism at various ages. A practical hands-on guide on how to perform these tests is also provided.
Isidori
Andrea M
AM
Department of Medical Pathophysiology (DFM-Fisiopatologia Medica), Sapienza University of Rome, Rome, Italy.
Giannetta
Elisa
E
Lenzi
Andrea
A
D000328:Adult; D006063:Chorionic Gonadotropin; D002996:Clomiphene; D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone / Q000172:deficiency; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008297:Male; D013733:Testicular Diseases / Q000175:diagnosis; D013737:Testis / Q000503:physiopathology
D006063:Chorionic Gonadotropin; D005300:Fertility Agents, Female; D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone